Open, noncomparative trial of azithromycin in the treatment of M.avium [Mycobacterium avium] complex (MAC) lung disease
Phase of Trial: Phase IV
Latest Information Update: 25 May 2017
At a glance
- Drugs Azithromycin (Primary)
- Indications Mycobacterium avium complex infections
- Focus Therapeutic Use
- 19 May 2017 Status changed from active, no longer recruiting to completed.
- 15 Feb 2008 New trial record.